Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
96 studies found for:    Chest X Ray | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)
Condition: HIV, Inflammation
Interventions: Drug: Assess Safety;   Drug: Effect of drug on viral load;   Drug: Effect of drug on T-cell count;   Drug: Effect of drug on inflammatory biomarkers
22 Recruiting Pilot Trial of Allogeneic Blood or Marrow Transplanation for Primary Immunodeficiencies
Conditions: Primary T-cell Immunodeficiency Disorders;   Common Variable Immunodeficiency;   Immune System Diseases;   Autoimmune Lymphoproliferative;   Lymphoproliferative Disorders
Interventions: Drug: Immunosuppression Only Conditioning;   Drug: Reduced Intensity Conditioning;   Drug: Myeloablative Conditioning;   Drug: GVHD Prophylaxis;   Procedure: Allo BMT
23 Recruiting Longitudinal Observational Study of Severe Asthma
Condition: Asthma
Intervention:
24 Recruiting Pomalidomide for Kaposi Sarcoma in People With or Without HIV
Conditions: Kaposi Sarcoma;   Sarcoma, Kaposi
Intervention: Drug: Pomalidomide
25 Recruiting Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
Conditions: CVID;   Enteropathy;   Chronic Diarrhea;   Maldigestion;   Malabsorption
Intervention: Biological: Ustekinumab
26 Recruiting PET Imaging and Lymph Node Assessment of IRIS in People With AIDS
Condition: Immune Reconstitution Inflammatory Syndrome
Intervention:
27 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
28 Recruiting Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms;   Colorectal or Kidney Neoplasms;   Pancreatic Neoplasms;   Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive;   Melanoma;   CLL
Intervention: Drug: NK cells +CliniMACs CD3 and CD56 systems
29 Recruiting Study and Treatment of Inflammatory Muscle Diseases
Conditions: Autoimmune Disease;   Dermatomyositis;   Inclusion Body Myositis;   Myositis;   Polymyositis
Intervention:
30 Recruiting Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients
Conditions: HIV Infection;   Immunologic Deficiency Syndrome
Intervention:
31 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir/ & Emtricitabine;   Drug: Tenofovir
32 Recruiting A Prospective Natural History Study of Patients With Syringomyelia
Conditions: Syringomyelia;   Arnold Chiari Deformity
Intervention:
33 Recruiting Evaluation of Patients With Immune Function Abnormalities
Condition: Immune System Diseases
Intervention:
34 Recruiting Adult and Juvenile Myositis
Conditions: Dermatomyositis;   Polymyositis;   Inclusion Body Myositis
Intervention:
35 Recruiting Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients
Condition: Anthrax
Intervention:
36 Recruiting Metastasectomy Study in Renal Cell Carcinoma (RCC)
Condition: Kidney Cancer
Intervention: Other: Evaluation
37 Recruiting Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)
Condition: Tuberculosis
Interventions: Behavioral: Community-based intervention;   Other: Standard of care
38 Recruiting Sustained Aeration of Infant Lungs Trial
Conditions: Preterm Birth;   Extreme Prematurity
Interventions: Procedure: Sustained Inflation;   Procedure: Standard of Care
39 Recruiting Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis
Condition: Sarcoidosis; Antimycobacterial Therapy;
Interventions: Drug: Levofloxacin;   Drug: Ethambutol;   Drug: Azithromycin;   Drug: Rifampin;   Drug: Placebo
40 Recruiting Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
Conditions: Esophageal Neoplasms;   Lung Neoplasms;   Mesothelioma;   Thymus Neoplasms;   Neoplasms, Germ Cell and Embryonal
Intervention: Drug: Mithramycin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.